Appropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF) : A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi Arabia
BACKGROUND: Establishment of thromboembolism prevention remains a challenge despite the widespread consensus that thromboprophylaxis safely reduces patient morbidity and mortality. Dabigatran is a nonvitamin K antagonist oral anticoagulant (NOAC) which reduces the risk of thromboembolism. Proper dos...
Ausführliche Beschreibung